Advertisement
Journal Home
Search for

Volume 45, Supplement, Pages S7-S15 (August 2004)


View previous. 3 of 30 View next.

The epidemiology of asbestos-related diseases

Jacek NiklinskiaCorresponding Author Informationemail address, Wieslawa Niklinskab, Elżbieta Chyczewskac, Jerzy Laudanskia, Wojciech Naumnikc, Lech Chyczewskid, Eric Pluygerse

Abstract 

Asbestos has been recognised as a potential health hazard since the 1940s. Of the two major species of asbestos; white asbestos (chrysotile) and blue asbestos (crocidolite), both of which are hazardous. The workers at extraction facilities are at the greatest risk of exposure to asbestos and, therefore, the development of asbestos-related diseases, commonly mesothelioma. However, other individuals at a high risk of exposure include asbestos-cement workers, insulation workers and ship-yard workers. Environmental exposure to asbestos can occur as a result of living in areas either characterised by natural outcrops of asbestos or asbestos-related materials, or those close to asbestos-producing or -using plants. Unfortunately, man-made fibre alternatives to asbestos, such as rock and slag-wool and glass wool, have also been shown to have a detrimental effect on human health. A characteristic of mesothelioma is that there is a long latency period (20–30 years) before the signs and symptoms of the disease become apparent. In addition, diagnosis of the disease can be difficult. The use of biological markers, such as tissue polypeptide antigen, may play a useful role in the early detection of the disease in individuals at risk.

a Department of Thoracic Surgery, Medical Academy of Bialystok, 24A M. Sklodowska-Curie Str., 15-276 Bialystok, Poland

b Department of Histology and Embryology, Medical Academy of Bialystok, Bialystok, Poland

c Department of Pneumonology, Medical Academy of Bialystok, Bialystok, Poland

d Department of Clinical Molecular Biology, Medical Academy of Bialystok, Bialystok, Poland

e Oncology Department (Honorary), Jolimont Hospital, La Louviere, Belgium

Corresponding Author InformationCorresponding author. Fax: +48-85-7485988.

PII: S0169-5002(04)00164-3

doi:10.1016/j.lungcan.2004.04.008


View previous. 3 of 30 View next.